Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a vaccine manufacturing plant in northwest England, blaming the new Labour government ...

Donald Trump has blamed diversity, equity, and inclusion as a reason the U.S. was “going to hell” as the president continues ...

Analysts say the adoption of GLP-1 drugs, the expansion of AI and the growth of multi-billion-dollar M&A deals chart an unpredictable path for the industry this year.

Emeryville newsletter covering the second half of January includes 5 stories relevant to Emeryville that you may have missed.

Baker Hughes reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of $0.70, compared to the forecasted $0.63. The company also exceeded revenue ...

As global markets continue to navigate the evolving landscape marked by political developments and economic shifts, U.S. stocks have been buoyed by optimism surrounding potential trade deals and ...

Despite having an ambitious divestment target of Rs 50,000 crore for FY25, only 18% has been achieved till November 2024. For ...